Recent progress of ICP-MS in the development of metal-based drugs and diagnostic agents-Reference-Cited by-同舟云学术

Recent progress of ICP-MS in the development of metal-based drugs and diagnostic agents

Published:2014 Issue:6 Volume:29 Page:1058-1072
ISSN:0267-9477
Container-title:J. Anal. At. Spectrom.
language:en
Short-container-title:J. Anal. At. Spectrom.

Author:

Timerbaev Andrei R.¹²³

Affiliation:

1. Vernadsky Institute of Geochemistry and Analytical Chemistry

2. Russian Academy of Sciences

3. Moscow, Russia

Abstract

Critical analysis of current capabilities, limitations, and trends of ICP-MS applied to the development of metal-based medicines is conducted.

Publisher

Royal Society of Chemistry (RSC)

Subject

Spectroscopy,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2014/JA/C3JA50394A

Reference117 articles.

1. New metal complexes as potential therapeutics

2. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents , ed. M. Gielen and E. R. T. Tiekink , Wiley , New York, USA , 2005 , p. 598

3. Analytical methodologies for metallomics studies of antitumor Pt-containing drugs

4. Recent developments in ruthenium anticancer drugs

5. L. Messori and C.Gabbiani , in Metal Compounds in Cancer Chemotherapy , ed. J. M. Perez , M. A. Fuertes and C. Alonso , Research Signpost , Kerala, India , 2005 , p. 355

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent development of CE-ICP-MS in biospeciation research and analysis: from anticancer drugs to nanoparticles and beyond;TrAC Trends in Analytical Chemistry;2024-09

2. A novel isatin Schiff based cerium complex: synthesis, characterization, antimicrobial activity and molecular docking studies;BMC Genomics;2024-02-08

3. Photosubstitution and photoreduction of a diazido platinum(iv) anticancer complex;Dalton Transactions;2024

4. A de novo nanoplatform for the delivery of metal-based drugs studied with high-resolution ICP-MS;Talanta;2023-02

5. Versatile analytical methodology for evaluation of drug-like properties of potentially multi-targeting anticancer metallodrugs;Analytical Sciences;2022-02-21